HSPA9 and cancer: Based on the fact that mortalin is overexpressed on the surface of aggressive and metastatic cancer cells [49,50,51], we recruited DSPE-PEG-NHS and unique anti-mortalin antibody (that possesses cell-internalization characteristics) to target, these nanoparticles selectively to cancer cells.